Submitted by Anonymous (not verified) on 15 January 2026 - 14:05
Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 6, Status: Authorised